- Home
- INZY vs WIA Comparison
INZY vs WIA Comparison
Compare INZY & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- WIA
- Stock Information
- Founded
- INZY 2015
- WIA 2003
- Country
- INZY United States
- WIA United States
- Employees
- INZY N/A
- WIA N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- WIA Trusts Except Educational Religious and Charitable
- Sector
- INZY Health Care
- WIA Finance
- Exchange
- INZY Nasdaq
- WIA Nasdaq
- Market Cap
- INZY 256.3M
- WIA 192.9M
- IPO Year
- INZY 2020
- WIA N/A
- Fundamental
- Price
- INZY N/A
- WIA $8.39
- Analyst Decision
- INZY Buy
- WIA
- Analyst Count
- INZY 9
- WIA 0
- Target Price
- INZY $15.22
- WIA N/A
- AVG Volume (30 Days)
- INZY 989.2K
- WIA 39.2K
- Earning Date
- INZY 08-05-2025
- WIA 01-01-0001
- Dividend Yield
- INZY N/A
- WIA 12.29%
- EPS Growth
- INZY N/A
- WIA N/A
- EPS
- INZY N/A
- WIA N/A
- Revenue
- INZY N/A
- WIA N/A
- Revenue This Year
- INZY N/A
- WIA N/A
- Revenue Next Year
- INZY N/A
- WIA N/A
- P/E Ratio
- INZY N/A
- WIA N/A
- Revenue Growth
- INZY N/A
- WIA N/A
- 52 Week Low
- INZY $0.72
- WIA $7.56
- 52 Week High
- INZY $6.24
- WIA $8.91
- Technical
- Relative Strength Index (RSI)
- INZY 82.67
- WIA 65.05
- Support Level
- INZY $3.94
- WIA $8.25
- Resistance Level
- INZY $3.97
- WIA $8.46
- Average True Range (ATR)
- INZY 0.01
- WIA 0.07
- MACD
- INZY -0.08
- WIA 0.01
- Stochastic Oscillator
- INZY 100.00
- WIA 70.37
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.